uniQure N.V.
QURE
Market Cap$895.98M
Close$
$-3.38
119% downside
Current Fair Value
119% downsideOvervalued by 119% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $895.98 Million |
|---|---|
| Enterprise Value | $714.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.92 |
| Beta | 0.1 |
| Outstanding Shares | 54,807,967 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.5 |
|---|---|
| PEG | 13.63 |
| Price to Sales | - |
| Price to Book Ratio | -17.73 |
| Enterprise Value to Revenue | 49.83 |
| Enterprise Value to EBIT | -3.88 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | -18.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About uniQure N.V.
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to tr...